Gerresheimer AG (GRRMF)
OTCMKTS · Delayed Price · Currency is USD
51.41
0.00 (0.00%)
Jan 7, 2026, 4:00 PM EST
Gerresheimer AG Market Cap
Gerresheimer AG has a market cap or net worth of $1.12 billion as of January 8, 2026. Its market cap has decreased by -57.26% in one year.
Market Cap
1.12B
Enterprise Value
3.68B
Revenue
2.63B
Ranking
n/a
PE Ratio
40.94
Stock Price
$51.41
Market Cap Chart
Since June 11, 2007, Gerresheimer AG's market cap has decreased from 1.61B to 1.12B, a decrease of -30.51%. That is a compound annual growth rate of -1.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 1.12B | -0.22% |
| Dec 30, 2025 | 1.12B | -55.96% |
| Dec 30, 2024 | 2.54B | -29.36% |
| Dec 29, 2023 | 3.60B | 70.93% |
| Dec 30, 2022 | 2.11B | -30.02% |
| Dec 30, 2021 | 3.01B | -11.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 503.78M |
| Northwest Biotherapeutics | 445.03M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 365.15M |
| Silence Therapeutics | 273.96M |